QQ客服 官方微博 反馈留言

	Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways
	Wang, Jing; He, Fang; Chen, Lingqiang; Li, Qin; Jin, Song; Zheng, Hongmei; Lin, Jun; Zhang, Hong; Ma, Sha; Mei, Jian
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2018
卷号	105
关键词	Resveratrol miR-21 pulmonary fibrosis TGF-beta 1/Smad MAPK/AP-1 pathway
ISSN号	0753-3322
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3415955
专题	昆明医科大学
推荐引用方式 GB/T 7714	Wang, Jing,He, Fang,Chen, Lingqiang,et al. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,105.
APA	Wang, Jing.,He, Fang.,Chen, Lingqiang.,Li, Qin.,Jin, Song.,...&Yu, Juan.(2018).Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways.BIOMEDICINE & PHARMACOTHERAPY,105.
MLA	Wang, Jing,et al."Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways".BIOMEDICINE & PHARMACOTHERAPY 105(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。